These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
996 related articles for article (PubMed ID: 24907749)
1. One-pot facile synthesis of PEGylated superparamagnetic iron oxide nanoparticles for MRI contrast enhancement. Dai L; Liu Y; Wang Z; Guo F; Shi D; Zhang B Mater Sci Eng C Mater Biol Appl; 2014 Aug; 41():161-7. PubMed ID: 24907749 [TBL] [Abstract][Full Text] [Related]
2. One-pot synthesis of water-soluble superparamagnetic iron oxide nanoparticles and their MRI contrast effects in the mouse brains. Wang J; Zhang B; Wang L; Wang M; Gao F Mater Sci Eng C Mater Biol Appl; 2015 Mar; 48():416-23. PubMed ID: 25579942 [TBL] [Abstract][Full Text] [Related]
3. Facile synthesis of ultrasmall PEGylated iron oxide nanoparticles for dual-contrast T1- and T2-weighted magnetic resonance imaging. Hu F; Jia Q; Li Y; Gao M Nanotechnology; 2011 Jun; 22(24):245604. PubMed ID: 21508500 [TBL] [Abstract][Full Text] [Related]
5. Long-circulating PEGylated manganese ferrite nanoparticles for MRI-based molecular imaging. Pernia Leal M; Rivera-Fernández S; Franco JM; Pozo D; de la Fuente JM; García-Martín ML Nanoscale; 2015 Feb; 7(5):2050-9. PubMed ID: 25554363 [TBL] [Abstract][Full Text] [Related]
6. Synthesis Of PEG-Coated, Ultrasmall, Manganese-Doped Iron Oxide Nanoparticles With High Relaxivity For T Xiao S; Yu X; Zhang L; Zhang Y; Fan W; Sun T; Zhou C; Liu Y; Liu Y; Gong M; Zhang D Int J Nanomedicine; 2019; 14():8499-8507. PubMed ID: 31695377 [TBL] [Abstract][Full Text] [Related]
7. Superparamagnetic iron oxide nanoparticles conjugated with folic acid for dual target-specific drug delivery and MRI in cancer theranostics. Huang Y; Mao K; Zhang B; Zhao Y Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):763-771. PubMed ID: 27770953 [TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo experiments with iron oxide nanoparticles functionalized with DEXTRAN or polyethylene glycol for medical applications: magnetic targeting. Mojica Pisciotti ML; Lima E; Vasquez Mansilla M; Tognoli VE; Troiani HE; Pasa AA; Creczynski-Pasa TB; Silva AH; Gurman P; Colombo L; Goya GF; Lamagna A; Zysler RD J Biomed Mater Res B Appl Biomater; 2014 May; 102(4):860-8. PubMed ID: 24458920 [TBL] [Abstract][Full Text] [Related]
10. Effect of PEG molecular weight on stability, T₂ contrast, cytotoxicity, and cellular uptake of superparamagnetic iron oxide nanoparticles (SPIONs). Park YC; Smith JB; Pham T; Whitaker RD; Sucato CA; Hamilton JA; Bartolak-Suki E; Wong JY Colloids Surf B Biointerfaces; 2014 Jul; 119():106-14. PubMed ID: 24877593 [TBL] [Abstract][Full Text] [Related]
11. Biodistribution of biodegradable polymeric nano-carriers loaded with busulphan and designed for multimodal imaging. Asem H; Zhao Y; Ye F; Barrefelt Å; Abedi-Valugerdi M; El-Sayed R; El-Serafi I; Abu-Salah KM; Hamm J; Muhammed M; Hassan M J Nanobiotechnology; 2016 Dec; 14(1):82. PubMed ID: 27993139 [TBL] [Abstract][Full Text] [Related]
12. Synthesis of pseudopolyrotaxanes-coated Superparamagnetic Iron Oxide Nanoparticles as new MRI contrast agent. Hosseini F; Panahifar A; Adeli M; Amiri H; Lascialfari A; Orsini F; Doschak MR; Mahmoudi M Colloids Surf B Biointerfaces; 2013 Mar; 103():652-7. PubMed ID: 23199519 [TBL] [Abstract][Full Text] [Related]
13. The effect of metal ions on endogenous melanin nanoparticles used as magnetic resonance imaging contrast agents. Chen A; Sun J; Liu S; Li L; Peng X; Ma L; Zhang R Biomater Sci; 2020 Jan; 8(1):379-390. PubMed ID: 31728481 [TBL] [Abstract][Full Text] [Related]
15. Promoting the Delivery of Nanoparticles to Atherosclerotic Plaques by DNA Coating. Zhang L; Tian XY; Chan CKW; Bai Q; Cheng CK; Chen FM; Cheung MSH; Yin B; Yang H; Yung WY; Chen Z; Ding F; Leung KC; Zhang C; Huang Y; Lau JYW; Choi CHJ ACS Appl Mater Interfaces; 2019 Apr; 11(15):13888-13904. PubMed ID: 30516979 [TBL] [Abstract][Full Text] [Related]
16. The labeling of stem cells by superparamagnetic iron oxide nanoparticles modified with PEG/PVP or PEG/PEI. Yang G; Ma W; Zhang B; Xie Q Mater Sci Eng C Mater Biol Appl; 2016 May; 62():384-90. PubMed ID: 26952437 [TBL] [Abstract][Full Text] [Related]
17. Non-immunogenic dextran-coated superparamagnetic iron oxide nanoparticles: a biocompatible, size-tunable contrast agent for magnetic resonance imaging. Unterweger H; Janko C; Schwarz M; Dézsi L; Urbanics R; Matuszak J; Őrfi E; Fülöp T; Bäuerle T; Szebeni J; Journé C; Boccaccini AR; Alexiou C; Lyer S; Cicha I Int J Nanomedicine; 2017; 12():5223-5238. PubMed ID: 28769560 [TBL] [Abstract][Full Text] [Related]
18. Magnetic PEGylated Pt3Co nanoparticles as a novel MR contrast agent: in vivo MR imaging and long-term toxicity study. Yin S; Li Z; Cheng L; Wang C; Liu Y; Chen Q; Gong H; Guo L; Li Y; Liu Z Nanoscale; 2013 Dec; 5(24):12464-73. PubMed ID: 24165858 [TBL] [Abstract][Full Text] [Related]
19. Synthesis, characterization and theranostic evaluation of Indium-111 labeled multifunctional superparamagnetic iron oxide nanoparticles. Zolata H; Abbasi Davani F; Afarideh H Nucl Med Biol; 2015 Feb; 42(2):164-70. PubMed ID: 25311750 [TBL] [Abstract][Full Text] [Related]
20. Effect of surface coating on the biocompatibility and in vivo MRI detection of iron oxide nanoparticles after intrapulmonary administration. Al Faraj A; Shaik AP; Shaik AS Nanotoxicology; 2015; 9(7):825-34. PubMed ID: 26356541 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]